DE:2I9 Stock Latest News
Company AnnouncementsKDventures writes down Umecrine Cognition stake after golexanolone trial setback2d ago
Company AnnouncementsKDventures Portfolio Firm Wins Key U.S. Patent for PBC Drug Golexanolone1w ago
Company AnnouncementsKDventures Portfolio Firm Advances Malaria Drug After Key Trial Publication1w ago
Company AnnouncementsKDventures portfolio hit gains top billing for PBC fatigue study1w ago- Company AnnouncementsKDventures CSO John Öhd Shifts to Senior Advisor Role to Focus on Modus Therapeutics2w ago
Company AnnouncementsKDventures portfolio company Modus Therapeutics pauses kidney disease trial after serious adverse event2w agoCompany AnnouncementsKDventures portfolio firm gains Michael J. Fox Foundation spotlight for Parkinson’s program3w ago
Company AnnouncementsKDventures Portfolio Firm Completes Key Golexanolone Trial in PBC1M ago
Company AnnouncementsKDventures Portfolio Firm Wins Key U.S. Patents for Next-Gen Neurodegeneration Drugs1M ago
Company AnnouncementsModus Therapeutics Raises SEK 7.6m in Directed Share Issue Backed by KDventures1M ago
Company AnnouncementsKDventures Hit by Major Portfolio Write-Downs Amid Increased Investment Activity2M ago
Company AnnouncementsKDventures’ Umecrine Cognition Completes Enrollment in Key PBC Trial3M agoCompany AnnouncementsKDventures writes down PharmNovo stake as portfolio company raises SEK 39 million for phase 2 trial3M ago
Company AnnouncementsKDventures Portfolio Drug AC01 in Heart Failure Spotlight After Lancet Publication4M ago- Company AnnouncementsKDventures’ Umecrine Cognition trial of golexanolone advances unchanged after interim analysis4M ago
Company AnnouncementsKDventures AB Raises SEK 23.9 Million in Directed Share Issue to Fund KDev Investment4M ago
Company AnnouncementsKDventures Plans Directed Share Issue to Fund Rosetta Deal and Simplify Portfolio Structure4M ago
Company AnnouncementsKDventures writes down Umecrine Cognition stake as it backs new share issue4M agoCompany AnnouncementsKDventures Portfolio Firm Highlights Severe Fatigue as Key Unmet Need in PBC5M ago
Company AnnouncementsKDventures Unit Flags Unmet Need in PBC as CNS Drug Golexanolone Advances5M ago